AminologicsLtd's earnings have been declining at an average annual rate of -17%, while the Chemicals industry saw earnings declining at 0.3% annually. Revenues have been declining at an average rate of 3.6% per year. AminologicsLtd's return on equity is 4%, and it has net margins of 10%.
How AminologicsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A074430 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
22,676
2,259
5,809
207
31 Dec 25
22,020
3,522
5,611
140
30 Sep 25
19,516
1,952
5,220
155
30 Jun 25
15,905
-942
5,094
134
31 Mar 25
16,581
-581
4,930
161
31 Dec 24
16,790
-1,620
4,966
113
30 Sep 24
20,886
1,857
4,495
1,246
30 Jun 24
22,662
2,837
4,479
1,225
31 Mar 24
21,726
2,575
4,493
1,236
31 Dec 23
20,887
2,436
4,527
1,307
30 Sep 23
18,798
-13,256
5,396
165
30 Jun 23
22,265
-10,122
5,574
199
31 Mar 23
23,275
-9,357
5,530
210
31 Dec 22
27,337
-7,282
5,305
216
30 Sep 22
27,856
5,746
5,383
208
30 Jun 22
24,633
4,128
4,937
342
31 Mar 22
26,602
7,717
4,629
382
31 Dec 21
22,849
5,360
4,405
474
30 Sep 21
20,596
7,321
3,976
563
30 Jun 21
21,369
7,073
3,918
460
31 Mar 21
17,996
3,442
3,778
405
31 Dec 20
17,651
2,140
3,805
340
30 Sep 20
18,312
-1,468
3,714
284
30 Jun 20
17,219
-2,180
3,761
264
31 Mar 20
17,570
-2,789
3,867
297
31 Dec 19
18,980
-1,201
3,578
226
30 Sep 19
18,964
5,909
-124
202
30 Jun 19
19,226
6,864
-343
202
31 Mar 19
20,061
8,182
-488
137
31 Dec 18
18,450
7,996
-581
161
30 Sep 18
17,758
2,977
2,389
269
30 Jun 18
17,335
2,307
2,164
268
31 Mar 18
16,638
883
2,062
251
31 Dec 17
16,835
542
1,897
225
30 Sep 17
16,463
-3,569
2,114
195
30 Jun 17
16,845
-3,520
2,058
171
31 Mar 17
16,541
-3,602
2,179
167
31 Dec 16
16,366
-3,742
2,335
153
30 Sep 16
18,326
2,891
2,145
54
30 Jun 16
17,161
2,990
2,417
58
31 Mar 16
14,050
-1,447
2,314
63
31 Dec 15
10,997
-2,825
2,359
77
30 Sep 15
6,404
-10,069
2,946
114
Quality Earnings: A074430 has a large one-off loss of ₩1.2B impacting its last 12 months of financial results to 31st March, 2026.
Growing Profit Margin: A074430 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A074430's earnings have declined by 17% per year over the past 5 years.
Accelerating Growth: A074430 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A074430 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.2%).
Return on Equity
High ROE: A074430's Return on Equity (4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/06 16:10
End of Day Share Price
2026/07/06 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aminologics Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.